US8372047B1 - Device and method for topically applying medication to the lips - Google Patents

Device and method for topically applying medication to the lips Download PDF

Info

Publication number
US8372047B1
US8372047B1 US13/019,473 US201113019473A US8372047B1 US 8372047 B1 US8372047 B1 US 8372047B1 US 201113019473 A US201113019473 A US 201113019473A US 8372047 B1 US8372047 B1 US 8372047B1
Authority
US
United States
Prior art keywords
wall
lip
compartment
curved
anesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US13/019,473
Inventor
Otto J. Placik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US13/019,473 priority Critical patent/US8372047B1/en
Application granted granted Critical
Publication of US8372047B1 publication Critical patent/US8372047B1/en
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body
    • A61M35/003Portable hand-held applicators having means for dispensing or spreading integral media

Definitions

  • the present invention relates to devices that create a barrier around the lips of the mouth. More particularly, the present invention relates to devices that are capable of retaining a volume of material and retaining that material in constant contact with the lips for a prolonged period of time.
  • the lips of a person's mouth contain a particularly high density of nerve endings. This makes the lips very sensitive to the sense of touch. Furthermore, the dermis layer on the lips is thin as compared to other areas of the face. This adds to the sensitivity of the lips. It also makes the lips more prone to bleeding as compared to other areas of the face. To further complicate matters, the lips contain a high density of blood vessels. This cause the lips to bleed easily when injured. It also causes the lips to easily swell when injured. This anatomy is the underlying cause of the ease of receiving a “fat lip” even when the lips have received only a small injury.
  • topical anesthetics can be applied to the exterior of the lip.
  • the topical anesthetic numbs the exterior of the lip.
  • the topical anesthetic is typically applied by a physician rubbing the anesthetic onto the exterior of the lip with a swab or similar implement.
  • a physician rubbing the anesthetic onto the exterior of the lip with a swab or similar implement.
  • the numbing effect is very localized and typically does not numb nerve endings located deep within the lip tissue or on the interior of the lip. Consequently, if the lips are to receive injections, stitches, piercings, or any other treatment that affects the deeper tissue of the lip, the patient can still experience a significant amount of discomfort.
  • the second method of numbing lips is to numb the lips with injections of anesthetics. This completely numbs the tissue of the lip.
  • the act of injecting the anesthetic causes discomfort and injury to the lip.
  • injecting the anesthetic may cause some swelling of the lips. If a physician is performing a cosmetic procedure on the lips, such as fattening the lips with collagen, any swelling can cause obvious difficulties in the procedure as the doctor attempts to balance the shape of the lips.
  • the present invention is a system and method of topically applying an anesthetic, or other medication, to the upper lip and/or the lower lip of a user.
  • An applicator device is provided that has a curved first wall, a curved second wall, and a horizontal shelf that joins the first wall to the second wall.
  • the first wall, the second wall and the horizontal shelf combine to define both an upper lip compartment and a lower lip compartment.
  • a volume of the anesthetic, or other medication, is placed within either the upper lip compartment or the lower lip compartment.
  • the applicator device is partially placed in a person's mouth so that the second wall is positioned between the back of the lips and in front of the teeth. While in this position, the upper lip passes into the upper lip compartment and the lower lip passes into the lower lip compartment. Within the upper and lower compartments, the upper lip and the lower lip are contacted by the anesthetic. This enables the anesthetic to completely numb all the tissue of the lips. Once the lip tissue is completely numb, the applicator device is removed and the lips stand ready for a medical procedure.
  • FIG. 1 is a front perspective view of an exemplary embodiment of an applicator device
  • FIG. 2 is a rear perspective view of the exemplary embodiment of FIG. 1 ;
  • FIG. 3 is a top view of the exemplary embodiment of FIG. 1 ;
  • FIG. 4 is a cross-sectional view of the exemplary embodiment shown positioned in a user's mouth.
  • FIG. 5 is a rear perspective view of an alternate embodiment of the present invention applicator device.
  • the present invention device and method can be used to apply medication to only the upper lip or the lower lip
  • the embodiment illustrated shows the device configured to apply medication to both the upper lip and the lower lip. This embodiment is selected in order to set forth the best mode contemplated for the invention.
  • the illustrated embodiment is merely exemplary and should not be considered a limitation when interpreting the scope of the appended claims.
  • the applicator device 10 has an inner vertical wall 12 and an outer vertical wall 14 that are joined together by a horizontal shelf 16 .
  • the inner vertical wall 12 , the outer vertical wall 14 and the horizontal shelf 16 combine to create a curved upper lip chamber 18 and a curved lower lip chamber 20 .
  • the upper lip chamber 18 is sized to receive the upper lip 22 of a patient.
  • the lower lip chamber 20 is larger and is sized to receive the lower lip 24 of a patient.
  • Both the upper lip chamber 18 and the lower lip chamber 20 are filled with a viscous topical medication 26 , such as a topical anesthetic.
  • a viscous topical medication 26 such as a topical anesthetic.
  • the patient's lips 22 , 24 are placed into the applicator device 10 , wherein the patient's lips 22 , 24 come into contact with the medication 26 .
  • the lips 22 , 24 remain in contact with the medication 26 for as long as the lips 22 , 24 are in the applicator device 10 . In this manner, the patient's lips 22 , 24 are kept in contact with a substantial amount of medication 26 for a prolonged period of time.
  • the anesthetic numbs both the inside and the outside of the lips 22 , 24 .
  • the anesthetic can be applied to the lips in a volume sufficient, and for a time sufficient, to numb nerve endings deep within the lips 22 , 24 .
  • the inner vertical wall 12 has a first end 28 , a second end 30 , a top edge 32 , and a bottom edge 34 .
  • the inner vertical wall 12 is curved.
  • the curvature of the inner vertical wall 12 should be sufficient enough to pass around the exterior of the user's teeth 36 .
  • the closest distance D 1 between the opposite ends 28 , 30 of the inner vertical wall 12 is between 2 inches and three inches, with approximately 2.5 inches being preferred. Smaller sizes can be used for small adults, adolescents, and children.
  • the inner vertical wall 12 preferably has a thickness of between 0.05 inches and 0.15 inches so as to be thin enough to comfortably fit between a patients lips 22 , 24 and teeth 36 .
  • the height of the inner vertical wall 12 is between one inch and two inches, with approximately 1.5 inches being preferred. This height enables the inner vertical wall 12 to securely fit in the user's mouth behind the lips 22 , 24 and in front of the teeth 36 .
  • the height of the inner vertical wall 12 is too tall to enable the mouth to close if the inner vertical wall 12 were accidentally positioned behind the teeth 36 .
  • the applicator device 10 is therefore very structurally different from a traditional sports mouthpiece that surrounds the teeth rather than the lips.
  • Two small reliefs 38 , 39 are formed into the inner vertical wall 12 at its midpoint.
  • An upper relief 38 is formed into the top edge 32 of the inner vertical wall 12 .
  • a lower relief 39 is formed into the bottom edge 34 of the inner vertical wall 12 .
  • the upper relief 38 and the lower relief 39 are provided so that the inner vertical wall 12 does not interfere with the superior labial frenulum and the inferior labial fermium that extend between the lips 22 , 24 and gums, respectively.
  • the outer vertical wall 14 has an upper section 40 and a lower section 42 that join in a transition zone 44 .
  • the upper section 40 follows the curvature of the inner vertical wall 12 and maintains a constant distance of approximately 0.50 inches from the inner vertical wall 12 . This gap space is sufficient to accommodate the upper lip 22 of most adults.
  • the lower section 42 follows the curvature of the inner vertical wall 12 and maintains a constant distance of approximately 0.625 inches from the inner vertical wall 12 . This large gap space is sufficient to accommodate the lower lip 24 of most adults.
  • the horizontal ledge 16 joins the inner vertical wall 12 to the outer vertical wall 14 .
  • the horizontal ledge 16 joins the inner vertical wall 12 to the outer vertical wall 14 in a connection zone 46 that is centered about the midpoint of both the inner vertical wall 12 and the outer vertical wall 14 .
  • the inner vertical wall 12 and the outer vertical wall 14 are free to flex towards each other near their ends. This enables the applicator device 10 to better conform to the mouth size of a user and therefore become more comfortable.
  • the horizontal shelf 16 extends from the inner vertical wall 12 to approximately halfway between the top edge 32 and the bottom edge 34 of the inner vertical wall 12 . As a result, the inner vertical wall 12 extends both above and below the horizontal shelf 16 . Likewise, the horizontal shelf 16 extends from the transition zone 44 of the outer vertical wall 14 . As a result, the upper section 40 of the outer vertical wall 14 extends above the horizontal shelf 16 and the lower section 42 of the outer vertical wall 14 extends below the horizontal shelf 16 .
  • the inner vertical wall 12 , the horizontal shelf 16 and the upper section 40 of the outer vertical wall 14 create the upper lip chamber 18 .
  • the inner vertical wall 12 , the horizontal shelf 16 and the lower section 42 of the outer vertical wall 14 create the larger lower lip chamber 20 .
  • a volume of viscous medication 26 such as an anesthetic, is applied to the surfaces of both the upper lip chamber 18 and the lower lip chamber 20 .
  • the inner vertical wall 12 is then placed into the user's mouth, behind the lips 22 , 24 and in front of the teeth 36 .
  • the patient's upper lip 22 can be rested in the upper lip chamber 18 .
  • the patient's lower lip 24 can be placed in the lower lip chamber 20 .
  • the medication 26 with enough time to fully effect the tissue of the lips 22 , 24 . If the medication 26 is a topical anesthetic, the lips 22 , 24 are left in contact with the anesthetic until the lips 22 , 24 are completely numb. Once the lips 22 , 24 are numb, the application device 10 is removed and the physician is free to perform a medical procedure upon the lips 22 , 24 .
  • FIG. 5 an alternate embodiment of the present invention applicator 50 is shown.
  • This embodiment has the same configuration and parts as the embodiment of FIGS. 1-4 .
  • a conduit 52 is formed in the center of the applicator device 50 .
  • the conduit 52 has a first open end 54 that extends through the inner vertical wall 12 and an opposite second open end (not shown) that extends through the outer vertical wall 14 .
  • the presence of the conduit 52 enables a person to breathe better through their mouth while the applicator device 50 is being used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

A system and method of topically applying an anesthetic, or other medication, to one or both lips of the mouth. An applicator device is provided that has a curved first wall, a curved second wall, and a horizontal shelf that joins the first wall to the second wall. The first wall, the second wall and the horizontal shelf combine to define either one or two curved lip compartments. A volume of the anesthetic, or other medication, is placed within the curved lip compartments. The applicator device is partially placed in a person's mouth so that the second wall is positioned between the back of the lips and in front of the teeth. While in this position, the lip of the user passes into the curved lip compartment and is contacted by the anesthetic.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
In general, the present invention relates to devices that create a barrier around the lips of the mouth. More particularly, the present invention relates to devices that are capable of retaining a volume of material and retaining that material in constant contact with the lips for a prolonged period of time.
2. Prior Art Description
The lips of a person's mouth contain a particularly high density of nerve endings. This makes the lips very sensitive to the sense of touch. Furthermore, the dermis layer on the lips is thin as compared to other areas of the face. This adds to the sensitivity of the lips. It also makes the lips more prone to bleeding as compared to other areas of the face. To further complicate matters, the lips contain a high density of blood vessels. This cause the lips to bleed easily when injured. It also causes the lips to easily swell when injured. This anatomy is the underlying cause of the ease of receiving a “fat lip” even when the lips have received only a small injury.
Because the lips are highly sensitive, physicians often want to numb the lips before any medical procedure is performed on the lips. The numbing of the lips is traditionally preformed in one of two ways.
For minor procedures, topical anesthetics can be applied to the exterior of the lip. The topical anesthetic numbs the exterior of the lip. The topical anesthetic is typically applied by a physician rubbing the anesthetic onto the exterior of the lip with a swab or similar implement. As a result, only a small amount of anesthetic is applied. Therefore, the numbing effect is very localized and typically does not numb nerve endings located deep within the lip tissue or on the interior of the lip. Consequently, if the lips are to receive injections, stitches, piercings, or any other treatment that affects the deeper tissue of the lip, the patient can still experience a significant amount of discomfort.
The second method of numbing lips is to numb the lips with injections of anesthetics. This completely numbs the tissue of the lip. However, the act of injecting the anesthetic causes discomfort and injury to the lip. Furthermore, injecting the anesthetic may cause some swelling of the lips. If a physician is performing a cosmetic procedure on the lips, such as fattening the lips with collagen, any swelling can cause obvious difficulties in the procedure as the doctor attempts to balance the shape of the lips.
A need therefore exists for an improved device and method for numbing the lips that does not injure the lips or otherwise cause swelling of the lips. A need also exists for a new device and method for numbing the lips that can use topical anesthetics in amounts great enough to numb the exterior of the lip, the interior of the lip, and all the tissue there between. These needs are met by the present invention as described and claimed below.
SUMMARY OF THE INVENTION
The present invention is a system and method of topically applying an anesthetic, or other medication, to the upper lip and/or the lower lip of a user. An applicator device is provided that has a curved first wall, a curved second wall, and a horizontal shelf that joins the first wall to the second wall. The first wall, the second wall and the horizontal shelf combine to define both an upper lip compartment and a lower lip compartment.
A volume of the anesthetic, or other medication, is placed within either the upper lip compartment or the lower lip compartment. The applicator device is partially placed in a person's mouth so that the second wall is positioned between the back of the lips and in front of the teeth. While in this position, the upper lip passes into the upper lip compartment and the lower lip passes into the lower lip compartment. Within the upper and lower compartments, the upper lip and the lower lip are contacted by the anesthetic. This enables the anesthetic to completely numb all the tissue of the lips. Once the lip tissue is completely numb, the applicator device is removed and the lips stand ready for a medical procedure.
BRIEF DESCRIPTION OF THE DRAWINGS
For a better understanding of the present invention, reference is made to the following description of exemplary embodiments thereof, considered in conjunction with the accompanying drawings, in which:
FIG. 1 is a front perspective view of an exemplary embodiment of an applicator device;
FIG. 2 is a rear perspective view of the exemplary embodiment of FIG. 1;
FIG. 3 is a top view of the exemplary embodiment of FIG. 1;
FIG. 4 is a cross-sectional view of the exemplary embodiment shown positioned in a user's mouth; and
FIG. 5 is a rear perspective view of an alternate embodiment of the present invention applicator device.
DETAILED DESCRIPTION OF THE DRAWINGS
Although the present invention device and method can be used to apply medication to only the upper lip or the lower lip, the embodiment illustrated shows the device configured to apply medication to both the upper lip and the lower lip. This embodiment is selected in order to set forth the best mode contemplated for the invention. The illustrated embodiment, however, is merely exemplary and should not be considered a limitation when interpreting the scope of the appended claims.
Referring in combination to FIG. 1, FIG. 2, FIG. 3, and FIG. 4, the exemplary embodiment of the present invention applicator device 10 is illustrated. The applicator device 10 has an inner vertical wall 12 and an outer vertical wall 14 that are joined together by a horizontal shelf 16. The inner vertical wall 12, the outer vertical wall 14 and the horizontal shelf 16 combine to create a curved upper lip chamber 18 and a curved lower lip chamber 20. As will be explained in more detail, the upper lip chamber 18 is sized to receive the upper lip 22 of a patient. The lower lip chamber 20 is larger and is sized to receive the lower lip 24 of a patient. Both the upper lip chamber 18 and the lower lip chamber 20 are filled with a viscous topical medication 26, such as a topical anesthetic. The patient's lips 22, 24 are placed into the applicator device 10, wherein the patient's lips 22, 24 come into contact with the medication 26. The lips 22, 24 remain in contact with the medication 26 for as long as the lips 22, 24 are in the applicator device 10. In this manner, the patient's lips 22, 24 are kept in contact with a substantial amount of medication 26 for a prolonged period of time. If the medication 26 is a topical anesthetic, the anesthetic numbs both the inside and the outside of the lips 22, 24. Furthermore, the anesthetic can be applied to the lips in a volume sufficient, and for a time sufficient, to numb nerve endings deep within the lips 22, 24.
The inner vertical wall 12 has a first end 28, a second end 30, a top edge 32, and a bottom edge 34. The inner vertical wall 12 is curved. The curvature of the inner vertical wall 12 should be sufficient enough to pass around the exterior of the user's teeth 36. For an adult, the closest distance D1 between the opposite ends 28, 30 of the inner vertical wall 12 is between 2 inches and three inches, with approximately 2.5 inches being preferred. Smaller sizes can be used for small adults, adolescents, and children.
The inner vertical wall 12 preferably has a thickness of between 0.05 inches and 0.15 inches so as to be thin enough to comfortably fit between a patients lips 22, 24 and teeth 36. The height of the inner vertical wall 12, from its bottom edge 34 to its top edge 32, is between one inch and two inches, with approximately 1.5 inches being preferred. This height enables the inner vertical wall 12 to securely fit in the user's mouth behind the lips 22, 24 and in front of the teeth 36. However, the height of the inner vertical wall 12 is too tall to enable the mouth to close if the inner vertical wall 12 were accidentally positioned behind the teeth 36. The applicator device 10 is therefore very structurally different from a traditional sports mouthpiece that surrounds the teeth rather than the lips.
Two small reliefs 38, 39 are formed into the inner vertical wall 12 at its midpoint. An upper relief 38 is formed into the top edge 32 of the inner vertical wall 12. Likewise, a lower relief 39 is formed into the bottom edge 34 of the inner vertical wall 12. The upper relief 38 and the lower relief 39 are provided so that the inner vertical wall 12 does not interfere with the superior labial frenulum and the inferior labial fermium that extend between the lips 22, 24 and gums, respectively.
The outer vertical wall 14 has an upper section 40 and a lower section 42 that join in a transition zone 44. The upper section 40 follows the curvature of the inner vertical wall 12 and maintains a constant distance of approximately 0.50 inches from the inner vertical wall 12. This gap space is sufficient to accommodate the upper lip 22 of most adults.
The lower section 42 follows the curvature of the inner vertical wall 12 and maintains a constant distance of approximately 0.625 inches from the inner vertical wall 12. This large gap space is sufficient to accommodate the lower lip 24 of most adults.
The horizontal ledge 16 joins the inner vertical wall 12 to the outer vertical wall 14. The horizontal ledge 16 joins the inner vertical wall 12 to the outer vertical wall 14 in a connection zone 46 that is centered about the midpoint of both the inner vertical wall 12 and the outer vertical wall 14. This leaves open areas 48, 49 between the inner vertical wall 12 and the outer vertical wall 14 near the ends 28, 30 of the inner vertical wall 12. As a result, the inner vertical wall 12 and the outer vertical wall 14 are free to flex towards each other near their ends. This enables the applicator device 10 to better conform to the mouth size of a user and therefore become more comfortable.
The horizontal shelf 16 extends from the inner vertical wall 12 to approximately halfway between the top edge 32 and the bottom edge 34 of the inner vertical wall 12. As a result, the inner vertical wall 12 extends both above and below the horizontal shelf 16. Likewise, the horizontal shelf 16 extends from the transition zone 44 of the outer vertical wall 14. As a result, the upper section 40 of the outer vertical wall 14 extends above the horizontal shelf 16 and the lower section 42 of the outer vertical wall 14 extends below the horizontal shelf 16.
The inner vertical wall 12, the horizontal shelf 16 and the upper section 40 of the outer vertical wall 14 create the upper lip chamber 18. The inner vertical wall 12, the horizontal shelf 16 and the lower section 42 of the outer vertical wall 14 create the larger lower lip chamber 20.
A volume of viscous medication 26, such as an anesthetic, is applied to the surfaces of both the upper lip chamber 18 and the lower lip chamber 20. The inner vertical wall 12 is then placed into the user's mouth, behind the lips 22, 24 and in front of the teeth 36. When in this position, the patient's upper lip 22 can be rested in the upper lip chamber 18. Likewise, the patient's lower lip 24 can be placed in the lower lip chamber 20. Once the upper and lower lips 22, 24 are in the upper and lower lip chambers 18, 20, the lips 22, 24 come into contact with the medication 26. The lips 22, 24 can be left in contact with the medication 26 for a prolonged period of time. This provides the medication 26 with enough time to fully effect the tissue of the lips 22, 24. If the medication 26 is a topical anesthetic, the lips 22, 24 are left in contact with the anesthetic until the lips 22, 24 are completely numb. Once the lips 22, 24 are numb, the application device 10 is removed and the physician is free to perform a medical procedure upon the lips 22, 24.
Referring to FIG. 5, an alternate embodiment of the present invention applicator 50 is shown. This embodiment has the same configuration and parts as the embodiment of FIGS. 1-4. However, in this alternate embodiment, a conduit 52 is formed in the center of the applicator device 50. The conduit 52 has a first open end 54 that extends through the inner vertical wall 12 and an opposite second open end (not shown) that extends through the outer vertical wall 14. The presence of the conduit 52 enables a person to breathe better through their mouth while the applicator device 50 is being used.
It will be understood that the embodiments of the present invention that are illustrated and described are merely exemplary and that a person skilled in the art can make many variations to those embodiments. For instance, the dimensions of the inner vertical wall, outer vertical wall and horizontal shelf can all be varied to match different mouth sizes. All such embodiments are intended to be included within the scope of the present invention as defined by the claims.

Claims (16)

1. For use with a person having a mouth with a lip and teeth, a method of topically applying material to a person's lips, comprising the steps of:
providing an applicator device having a curved lip compartment defined between a first wall and a second wall, wherein said curved lip compartment defines a gap between said first wall and said second wall that is between 0.50 inches and 0.625 inches wide;
placing said material within said curved lip compartment between said first wall and said second wall; and
placing said second wall of said curved lip compartment within a person's mouth between the lip and teeth, wherein said lip passes into curved lip compartment and is brought into direct contact with said material therein.
2. The method according to claim 1, wherein said material is a topical anesthetic.
3. The method according to claim 1, wherein a horizontal shelf extends between said first wall and said second wall, wherein said first wall, said horizontal shelf and said second wall define three sides of said curved lip compartment.
4. The method according to claim 3, wherein said first wall and said second wall follow parallel paths, and said horizontal shelf lay perpendicular to both said first wall and said second wall.
5. The method according to claim 3, further including the step of providing at least one labial frenulum recess in said second wall.
6. For use with a person having a mouth with an upper lip, a lower lip, and teeth, a method of topically applying an anesthetic to said upper lip and said lower lip, comprising the steps of:
providing an applicator device having a curved first wall, a curved second wall, and a horizontal shelf that joins said first wall to said second wall, wherein said first wall, said second wall and said horizontal shelf combine to define an upper curved lip compartment and a lower curved lip compartment;
placing a volume of said anesthetic within said upper curved lip compartment and said lower curved lip compartment;
placing said second wall within a person's mouth and positioning said second wall between behind said upper lip and said lower lip in front of the teeth, wherein the upper lip passes into said upper curved lip compartment and the lower lip passes into said lower curved lip compartment, wherein the upper lip and the lower lip are contacted by said anesthetic.
7. The method according to claim 6, wherein said step of providing an applicator device includes providing an applicator device having a lower curved lip compartment that is larger than said upper curved lip compartment.
8. The method according to claim 6, wherein said first wall and said second wall follow parallel paths, and said horizontal shelf lay perpendicular to both said first wall and said second wall.
9. The method according to claim 6, further including the step of providing labial frenulum recesses in said second wall.
10. The method according to claim 6, wherein said upper curved lip compartment defines a gap between said first wall and said second wall that is at least 0.5 inches wide.
11. The method according to claim 10, wherein said lower curved lip compartment defines a gap between said first wall and said second wall that is no greater than 0.625 inches wide.
12. The method according to claim 6, wherein said first wall has two ends and said second wall has two ends, wherein said horizontal shell interconnects said first wall and said second wall in a center region midway between said first wall ends and said second wall ends.
13. The method according to claim 12, wherein open areas exist between said first wall and said second wall, proximate said first wall ends and said second wall ends where no horizontal shelf is present between said first wall and said second wall.
14. The method according to claim 6, further including the step of providing an open ended conduit that extends through said applicator device from said first wall to said second wall.
15. The method according to claim 6, wherein said second wall has a height of between one inch and two inches.
16. A method of topically applying an anesthetic to a lip of the mouth, said method comprising the steps of:
providing an applicator device that defines a curved lip compartment having an inner wall, an outer wall, a bottom shelf and an open top;
placing a volume of said anesthetic within said curved lip compartment; and
placing a user's lip into said curved lip compartment so that said inner wall is interposed between the user's lip and teeth, and where said lip is contacted by said anesthetic.
US13/019,473 2011-02-02 2011-02-02 Device and method for topically applying medication to the lips Expired - Fee Related US8372047B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/019,473 US8372047B1 (en) 2011-02-02 2011-02-02 Device and method for topically applying medication to the lips

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/019,473 US8372047B1 (en) 2011-02-02 2011-02-02 Device and method for topically applying medication to the lips

Publications (1)

Publication Number Publication Date
US8372047B1 true US8372047B1 (en) 2013-02-12

Family

ID=47631915

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/019,473 Expired - Fee Related US8372047B1 (en) 2011-02-02 2011-02-02 Device and method for topically applying medication to the lips

Country Status (1)

Country Link
US (1) US8372047B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1735221A (en) * 1928-09-25 1929-11-12 Temple Oliver Apparatus for applying medicaments to the lips
US4338928A (en) * 1980-09-05 1982-07-13 Martin Leonard G Lip shield and treatment device
US20030209254A1 (en) * 2002-05-13 2003-11-13 Ruggiero Joseph A. Lipstick applicator
US20090035718A1 (en) * 2007-08-03 2009-02-05 Logan Coffee Dental isolation block

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1735221A (en) * 1928-09-25 1929-11-12 Temple Oliver Apparatus for applying medicaments to the lips
US4338928A (en) * 1980-09-05 1982-07-13 Martin Leonard G Lip shield and treatment device
US20030209254A1 (en) * 2002-05-13 2003-11-13 Ruggiero Joseph A. Lipstick applicator
US20090035718A1 (en) * 2007-08-03 2009-02-05 Logan Coffee Dental isolation block

Similar Documents

Publication Publication Date Title
Storm et al. Palmar skin conductance compared to a developed stress score and to noxious and awakening stimuli on patients in anaesthesia
Gan et al. A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting
Emert et al. Enhanced deep-inspiration breath hold superior to high-frequency percussive ventilation for respiratory motion mitigation: A physiology-driven, MRI-guided assessment toward optimized lung cancer treatment with proton therapy
Rotava et al. Effects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: a randomised trial
Kollipara et al. Lip measurements and preferences in Asians and Hispanics: a brief review
CN106072810A (en) A kind of bra
US8372047B1 (en) Device and method for topically applying medication to the lips
Farrier et al. Gagging during impression making: techniques for reduction
Malhotra et al. Effect of head down tilt on heart rate variability
Soltani et al. The role of magnesium sulfate in tracheal intubation without muscle relaxation in patients undergoing ophthalmic surgery
Mengden et al. Use of automated blood pressure measurements in clinical trials and registration studies: data from the VALTOP Study
Jones et al. Electrical stimulation of acupuncture points and blood pressure responses to postural changes: a pilot study
CN211911908U (en) Hallux valgus corrector
Chhabra et al. Pleomorphic cutaneous sarcoidosis confined to lesions of vitiligo vulgaris in a patient with type 1 diabetes mellitus
CN205514624U (en) Clinical laboratory uses hemostix
Han et al. The simultaneous application of positive-end expiratory pressure with the Trendelenburg position minimizes respiratory fluctuations in internal jugular vein size
Norsworthy et al. Topical salicylic acid hypersensitivity
CN104687928B (en) Combined health care pillow
Lohan Trigeminal neuralgia-ayurveda approach: A case study
CN220025591U (en) Intradermal planting needle and package thereof
CN215385193U (en) A medical headgear with an integrated drug patch
CN209332393U (en) A kind of antifriction nursing backing plate of Cavity in Critical Patients ear
CN206526199U (en) A kind of liver disease bed
Babu et al. A comparative study of bupivacaine 0.5% and ropivacaine 0.5% for supraclavicular brachial plexus block (Perivascular approach)
Matsumoto et al. Relationship between cardiac output and onset of succinylcholine chloride action in electroconvulsive therapy patients

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20250212